We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MRC Technology and IBP CAS Collaboration Yields Humanized Anti-CD146 Antibody

News   Mar 20, 2013

 
MRC Technology and IBP CAS Collaboration Yields Humanized Anti-CD146 Antibody
 
 
 

RELATED ARTICLES

Boy With Rare Brain Tumor One of First in UK to Receive Proton Beam Therapy Treatment

News

A 15-year old from West Sussex, diagnosed with a brain tumor last August, will become one of the first patients in the UK to receive state-of-the-art proton beam therapy treatment at a new £125 million center opened in Manchester.

READ MORE

Immune System Protein Helps Suppress HIV

News

A new study reveals the role of a protein that serves to block HIV gene expression once it has entered human cells.

READ MORE

Probiotic Consumption Impacts Breast Milk Composition

News

The complex sugars found in human breastmilk, long believed to be fixed in their composition, may change in women who are taking probiotics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE